Literature DB >> 6863090

Site of pulmonary hypoxic vasoconstriction studied with arterial and venous occlusion.

T S Hakim, R P Michel, H Minami, H K Chang.   

Abstract

We applied the arterial and venous occlusion technique in an in situ, isolated left lower lobe preparation of a dog lung to compare the effects of hypoxia with the effects of airway pressure elevation, and the infusion of serotonin, norepinephrine, and histamine. The total arteriovenous pressure drop across the lobe was partitioned longitudinally into pressure drops across the relatively indistensible arteries (delta Pa) and veins (delta Pv) and across the middle distensible vessels (delta Pm). Hypoxia increased primarily delta Pm, as did elevation of airway pressure, whereas the vasoactive drugs increased either delta Pa or delta Pv. The increases in pulmonary arterial pressure (Pa) caused by hypoxia and by elevation of airway pressure were independent of blood flow rate, but increases in Pa induced by the vasoactive drugs were dependent on flow rate. We conclude that in the dog hypoxia acts primarily on small distensible vessels, whereas pulmonary vasoactive drugs constrict the relatively indistensible arteries and veins. It is possible that the increase in pulmonary vascular resistance during hypoxia did not involve smooth muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863090     DOI: 10.1152/jappl.1983.54.5.1298

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  9 in total

1.  Effects of alveolar hypoxia on pulmonary capillary beds.

Authors:  Y Fujita; H Yano; M Takaori
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

2.  Permeability of the endothelium and partitioning of the pulmonary blood flow resistance in isolated perfused pig lungs: effects of breed and age.

Authors:  P Gustin; B Urbain; A Delaunois; K Zeimes; M Ansay
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

3.  Halothane inhibits hypoxic pulmonary vasoconstriction in the presence of cyclooxygenase blockade.

Authors:  D Johnson; I Mayers; T Hurst
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

4.  Extent to which pulmonary vascular responses to PCO2 and PO2 play a functional role within the healthy human lung.

Authors:  Keith L Dorrington; George M Balanos; Nick P Talbot; Peter A Robbins
Journal:  J Appl Physiol (1985)       Date:  2010-02-25

Review 5.  Endothelium-derived relaxing factor and the pulmonary circulation.

Authors:  G Cremona; A T Dinh Xuan; T W Higenbottam
Journal:  Lung       Date:  1991       Impact factor: 2.584

6.  Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man.

Authors:  G Cremona; A M Wood; L W Hall; E A Bower; T Higenbottam
Journal:  J Physiol       Date:  1994-11-15       Impact factor: 5.182

Review 7.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

8.  High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management.

Authors:  Aibek E Mirrakhimov; Kingman P Strohl
Journal:  Open Cardiovasc Med J       Date:  2016-02-08

9.  Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry.

Authors:  Shoaib Fakhri; Kelly Hannon; Kelly Moulden; Ryan Peterson; Peter Hountras; Todd Bull; James Maloney; Teresa De Marco; Dunbar Ivy; Thenappan Thenappan; Jeffrey S Sager; John J Ryan; Sula Mazimba; Russel Hirsch; Murali Chakinala; Oksana Shlobin; Matthew Lammi; Dianne Zwicke; Jeffrey Robinson; Raymond L Benza; James Klinger; Daniel Grinnan; Stephen Mathai; David Badesch
Journal:  Pulm Circ       Date:  2020-11-10       Impact factor: 2.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.